NCT03555981

Brief Summary

The mortality effect of kangaroo mother care in stable newborns \<2000g is well established but mortality effect in unstable newborns is not conclusively known. This pragmatic clinical trial aims to investigate the mortality and clinical effects of early continuous Kangaroo Mother Care (KMC) compared to standard care in mild-moderately unstable neonates \<2000g in a resource limited hospital setting.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
279

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 8, 2018

Completed
12 days until next milestone

Study Start

First participant enrolled

May 20, 2018

Completed
25 days until next milestone

First Posted

Study publicly available on registry

June 14, 2018

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 20, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 20, 2020

Completed
3.5 years until next milestone

Results Posted

Study results publicly available

October 16, 2023

Completed
Last Updated

April 16, 2026

Status Verified

July 1, 2019

Enrollment Period

1.9 years

First QC Date

May 8, 2018

Results QC Date

September 22, 2021

Last Update Submit

March 25, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • All-cause Mortality

    All neonatal deaths within 28 postnatal days

    28 days

Secondary Outcomes (8)

  • Time to Death

    28 days of age

  • Cardio-respiratory Stability

    At 24 hours after start of intervention/control procedures

  • Number and Proportion of Participants With Hypothermia

    At 24 hours after start of intervention/control procedures

  • Weight Gain

    At 28 days of age

  • Exclusive Breastfeeding

    At time of hospital discharge, within study period, on average 2 weeks of age

  • +3 more secondary outcomes

Study Arms (2)

Early KMC

EXPERIMENTAL

Continuous kangaroo mother care started within 24h of hospital admission, aiming for minimum 18h/day and until hospital discharge with encouragement of KMC at home

Other: Early Kangaroo Mother Care

Standard care

ACTIVE COMPARATOR

Standard care under radiant heater or incubator until clinical stability criteria are met then intermittent or continuous Kangaroo mother care started at \>24h of hospital admission until hospital discharge with encouragement of KMC at home

Other: Standard care

Interventions

Continuous skin-to-skin contact between baby and mother/caregiver started within 24h of hospital admission

Also known as: Early skin-to-skin contact, Early kangaroo method
Early KMC

Incubator or radiant heater care until stable, off oxygen and \>24h of admission, at which point will start intermittent or continuous kangaroo mother care

Standard care

Eligibility Criteria

Age1 Hour - 24 Hours
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • New admission to study site during study period
  • Admission weight \<2000g
  • Age 1 - 24h at start of screening
  • Alive at enrolment
  • Availability of study bed
  • Written informed consent from parent or caregiver
  • Parent or caregiver available and willing to provide intervention, if necessary

You may not qualify if:

  • Congenital malformation incompatible with life or needing immediate surgical correction
  • Severe jaundice needing immediate management
  • Seizures
  • Clinically stable as assessed over pre-defined period of cardio-respiratory monitoring
  • Severely unstable as assessed over pre-defined period of cardio-respiratory monitoring
  • Completed triplet admission
  • Mother and/or neonate enrolled in another research study at time of hospital admission

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

MRC Unit The Gambia at LSHTM

Fajara, West Coast, The Gambia

Location

Related Publications (2)

  • Brotherton H, Gai A, Kebbeh B, Njie Y, Walker G, Muhammad AK, Darboe S, Jallow M, Ceesay B, Samateh AL, Tann CJ, Cousens S, Roca A, Lawn JE. Impact of early kangaroo mother care versus standard care on survival of mild-moderately unstable neonates <2000 grams: A randomised controlled trial. EClinicalMedicine. 2021 Aug 6;39:101050. doi: 10.1016/j.eclinm.2021.101050. eCollection 2021 Sep.

  • Brotherton H, Gai A, Tann CJ, Samateh AL, Seale AC, Zaman SMA, Cousens S, Roca A, Lawn JE. Protocol for a randomised trial of early kangaroo mother care compared to standard care on survival of pre-stabilised preterm neonates in The Gambia (eKMC). Trials. 2020 Mar 6;21(1):247. doi: 10.1186/s13063-020-4149-y.

MeSH Terms

Conditions

Premature BirthHypothermiaDeathBacterial Infections

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesBody Temperature ChangesSigns and SymptomsPathological Conditions, Signs and SymptomsPathologic ProcessesBacterial Infections and MycosesInfections

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Results Point of Contact

Title
Dr Helen Brotherton
Organization
London School of Hygiene & Tropical Medicine

Study Officials

  • Helen C Brotherton, MBChB

    London School of Hygiene and Tropical Medicine

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Individually randomised controlled superiority trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 8, 2018

First Posted

June 14, 2018

Study Start

May 20, 2018

Primary Completion

April 20, 2020

Study Completion

April 20, 2020

Last Updated

April 16, 2026

Results First Posted

October 16, 2023

Record last verified: 2019-07

Data Sharing

IPD Sharing
Will not share

Locations